Analysis of nearly 154,000 adults identifies key factors associated with shingles vaccine uptake and completion BELLEVUE, Wash.—June 18, 2026—Researchers from Truveta have found that uptake of the shingles vaccine Shingrix has increased substantially among adults...
Most patients with newly identified heart failure did not receive repeat heart function assessment, despite guideline recommendations BELLEVUE, Wash.—May 21, 2026—A new peer-reviewed study led by Truveta and collaborators at Yale School of Medicine, Yale New Haven...
Combining one of the nation’s most comprehensive real-world clinical datasets with next-generation behavioral AI models to transform care delivery and patient outcomes BELLEVUE, Wash. and SAN FRANCISCO, Calif.—May 12, 2026—Truveta and Knit Health today announced a...
New AI-powered experience removes the time-to-evidence barrier, enabling healthcare leaders to better understand and make informed decisions based on what’s happening in care today BELLEVUE, Wash.—April 28, 2026— Truveta today announced Truveta Intelligence, a new...
Providence President and CEO brings extensive experience advancing innovation, operations, and patient-centered care at scale. BELLEVUE, Wash.— March 31, 2026—Grounded in its mission of Saving Lives with Data, Truveta today announced the appointment of Erik Wexler,...
